Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 70

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 70
---
000 |     |                        |     | 6,900,000 |

(1) The LTI Grant Value referenced in the table differs from the sum of the Stock Award and Option Award grant date fair values referenced in the 2024 Summary Compensation Table. This is largely due to the timing and determination of the grant date fair value of SPS awards under ASC Topic 718. Under ASC Topic 718, SPS grant date fair values reflect a probable achievement level of the TSR performance condition as of grant date; however, this probable achievement level is not determined until after the Committee has determined the dollar amount of the LTI grant. Thus, an SPS award’s grant date fair value for accounting purposes may be higher or lower than the dollar amount of the LTI grant approved by the Committee if the TSR probable achievement level is above or below target, respectively. For more information on the TSR performance condition, please see the “Stock Awards” footnote for the 2024 Summary Compensation Table.

| Strategic Performance Share Program                                                                                                                                                |
| Our SPS program is designed to reward sustained long-term financial discipline and strategic accomplishments that benefit The Cigna Group and its shareholders over the long term. |

| Grants                                                                                                                                                                                                                 |
| At the time of grant, a total LTI dollar value is approved for each NEO. The SPS portion of the award is converted into a specific number of SPSs on the grant date based on The Cigna Group stock price on that date. |
| Vesting                                                                                                                                                                                                                |
| SPSs vest in the first quarter of the year following the end of the three-year performance period.                                                                                                                     |

| The Cigna Group| 2025 Notice of Annual Meeting of Shareholders and Proxy Statement |     | 71 |

| COMPENSATION MATTERS |

| Payout Determination                                                                                                                                                                                                                                               |
| The SPS awards can pay out from 0% to 200% based on Company achievement of two pre-established measures during the performance period. The payout factor is multiplied by each SPS award to determine the number of shares to be paid in respect of vested awards. |

| Measure:Adjusted income from operations per share, measured on a cumulative basis over three years, within the range of externally communicated targets excluding dividends |     |              |     | Measure:Relative TSR, compounded over the three-year performance period, relative to TSR peer group, for which the performance/payout curve is as follows:(1) (2) (3) |
| 85th percentile or higher